Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002164152 | SCV002478441 | likely benign | not provided | 2023-11-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002500362 | SCV002809053 | likely benign | Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome; Brain small vessel disease 1 with or without ocular anomalies; Hemorrhage, intracerebral, susceptibility to; Retinal arterial tortuosity; Microangiopathy and leukoencephalopathy, pontine, autosomal dominant | 2022-02-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004047058 | SCV004929930 | likely benign | Inborn genetic diseases | 2023-10-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV002164152 | SCV005093381 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | COL4A1: BS1 |